Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 18/20 | 0.67 |
| ▸ | ICAM1 | P05362 | 18/20 | 0.67 |
| ▸ | ITGAL | P20701 | 18/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5454772 | 0.93 | ITGB2 (0.69) | ITGB2ICAM1ITGAL | |
| SCHEMBL5458546 | 0.91 | ITGB2 (0.70) | ITGB2ICAM1ITGAL | |
| SCHEMBL5450311 | 0.88 | ITGB2 (0.69) | ITGB2ICAM1ITGAL | |
| SCHEMBL5446980 | 0.86 | ITGB2 (0.54) | ITGB2ICAM1ITGAL | |
| SCHEMBL5447640 | 0.85 | ITGB2 (0.69) | ITGB2ICAM1ITGALALDH1A1 | |
| SCHEMBL5447059 | 0.83 | ITGB2 (0.66) | ITGB2ICAM1ITGALMAPT | |
| SCHEMBL4895827 | 0.82 | NPC1 (0.44) | ITGB2ICAM1ITGALMEN1NPC1 | |
| SCHEMBL5220946 | 0.82 | ITGB2 (0.67) | ITGB2ICAM1ITGALMAPT | |
| SCHEMBL5196357 | 0.81 | ITGB2 (0.44) | ITGB2ICAM1ITGALMEN1NPC1 | |
| SCHEMBL5453167 | 0.80 | ITGB2 (0.68) | ITGB2ICAM1ITGALALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070259863-A1 | Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives | ICOS CORPORATION (US) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259863-A1 | Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives | AHR, ARSA, TST | ITGB2 3194/4885ICAM1 1146/4885ITGAL 2966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.